When Caroline Rivest broke her ankle a couple of years in the past, a physician prescribed her a robust opioid for 3 months to assist with the ache. She was hooked very quickly.
After her prescription ran out, she turned to the black market to maintain the withdrawal at bay.
“What struck me was that no one had instructed me simply how harmful it was. Simply how a lot it might change my life,” Rivest mentioned Thursday afternoon at an opioid-support centre in Montreal known as Méta d’Âme.
She was there filling out paperwork with Olivia Wawin, a lawyer concerned in a class-action lawsuit in opposition to eight producers and distributors of opioids that was given the inexperienced mild to proceed by Quebec’s Superior Court docket in 2024. When the lawsuit was licensed, it focused 16 corporations, a number of of which settled, paying a complete of about $22 million. Eight defendants stay.
However whereas the lawsuit is making its manner by means of the courts, Wawin and different attorneys within the case are having bother reaching potential members of the category motion. Some are experiencing homelessness; some are in jail; others are in long-term hospital care.
In response, the attorneys are visiting or sending data to pharmacies, jails, hospitals, and group organizations to attempt to meet eligible members the place they’re — therefore Thursday’s occasion at Méta d’Âme, a day centre the place present and former opioid customers can get companies together with adaptive housing. It’s one of many solely organizations in Quebec geared particularly towards opioid customers.
Get day by day Nationwide information
Get day by day Canada information delivered to your inbox so you will by no means miss the day’s prime tales.
Méta d’Âme is the place Rivest heard of the lawsuit and the potential for compensation. To be eligible as a member of the category motion, one should have been prescribed opioids and identified with opioid use dysfunction, often known as opioid dependancy.
Margo Siminovitch, with legislation agency Fishman Flanz Meland Paquin LLP, says some 13,000 folks in Quebec have been handled for opioid dependancy. “And people are those which are really getting remedy,” Siminovitch mentioned. “So, the issue is huge.”
Up to now, about 1,400 folks have registered as members, although they could not all be eligible.
Barbara Rivard and Christopher Kucyk are group employees at Méta d’Âme and mentioned Thursday that Siminovitch, Wawin and different attorneys within the case have the correct method. Rivard helped co-ordinate the conferences between Méta d’Âme purchasers and attorneys.
Kucyk mentioned he’s not shocked to listen to that fewer than 1,500 folks have signed onto the lawsuit as a result of these within the throes of dependancy “are simply desirous about their subsequent repair.” Others, Rivard mentioned, may be overwhelmed by the method or don’t know they might be eligible.
The category-action lawsuit alleges the eight corporations knew how addictive the medication have been however intentionally misrepresented these dangers, main customers to grow to be dependent. Siminovitch says an enchantment to the authorization of the category motion, filed by the defendants, was rejected.
In the course of the proceedings forward of the category motion’s authorization, defendants had argued that the lawsuit treats all opioids as in the event that they have been the identical, and that it supplied no proof that every one opioid medicines are addictive. The businesses denied misrepresenting the consequences of their medication and mentioned the category motion included corporations whose medication the consultant plaintiff had by no means consumed.
Whereas Siminovitch’s agency has about $22 million to distribute from the settlements, she says it’s been tough to achieve those that could be eligible for the cash.
The category motion’s lead plaintiff is former development employee Jean-François Bourassa, who had been hooked on an opioid for greater than a decade. He fell off a roof in 2005 and was prescribed an opioid for years till he selected to cease in 2018 after it wreaked havoc on his venous system.
“It was actually trivialized again then,” says Bourassa. “They weren’t even calling them opioids but, they have been simply painkillers.”
He says he must use methadone — an artificial opioid that helps scale back withdrawal signs — for the remainder of his life. His addition, he mentioned, has made his life a “dwelling hell” and he filed the lawsuit to assist others like him.
Opioids excluded from the lawsuit are OxyContin and OxyNEO, which have been the topic of a separate, nationwide class motion that was settled in 2023, in addition to opioids that have been solely utilized in hospitals.
The deadline to enroll as a possible member of the category motion is July 31, however Siminovitch is contemplating asking the courtroom to increase the deadline by six months to permit extra members to return ahead.
Siminovitch says attorneys will help all potential members with the required paperwork, which incorporates accessing medical and pharmaceutical information.
The Quebec lawsuit is separate from the Canada-wide class-action in opposition to greater than 40 opioid producers filed by British Columbia in 2018. These authorized proceedings are ongoing, although Purdue Pharma settled for $150 million in 2022.
© 2026 The Canadian Press